GSK-690693

SynDRA canonical compound SYN0045109 — structure-anchored drug synonym record

Primary target(s)	PRKCQ
Mechanism of action	Akt inhibitor

All known targets

AKT1
AKT2
AKT3
PRKCQ
LATS2
PAK4
PAK5
PAK6
PRKACA
PRKACB
PRKG1
PRKX

Mechanisms of action (all sources)

AKT1 INHIBITOR
AKT2 INHIBITOR
AKT3 INHIBITOR
LATS2 INHIBITOR
PAK4 INHIBITOR
PAK5 INHIBITOR
PAK6 INHIBITOR
PRKACA INHIBITOR
PRKACB INHIBITOR
PRKCQ INHIBITOR
PRKG1 INHIBITOR
PRKX INHIBITOR

Cross-references

PubChem CID: 16048642
ChEMBL: CHEMBL2140607
ChEBI: 91396
LINCS BRD: BRD-A87137733

Synonyms

SCHEMBL2195376
CHEBI:91396
KGPGFQWBCSZGEL-UHFFFAOYSA-N
HMS3244O05
HMS3244O06
HMS3244P05
HMS3295E23
HMS3654K04
AKOS032947266
SB16561
NCGC00387843-03
BRD-A87137733-001-01-5
4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(3-piperidinylmethoxy)-4-imidazo[4,5-c]pyridinyl]-2-methyl-3-butyn-2-ol
4-[2 - (4 - अमीनो -1,2,5 - ऑक्साडियाज़ोल -3 - वाईएल) -1 - एथिल -7 - (3 - पाइपरिडिनिलमेथॉक्सी) -4 - इमिडाज़ो [4,5 - सी]पाइरिडिनिल] -2 - मिथाइल -3 - ब्यूटिन -2 - ओएल

Look up GSK-690693 in the interactive SynDRA portal →